Anti-Hp IgG sero-status | | | | |
(Seronegative) | 0.9 | 1407 | 1.0 | — |
Borderline | 3.2 | 444 | 2.7 | 1.2;6.6 |
Seropositive | 0.8 | 526 | 0.7 | 0.2;2.4 |
Leisure time energy expenditure | | | | |
(Sedentary) | 2.1 | 572 | 1.0 | — |
Ambulatory | 1.0 | 1268 | 0.4 | 0.1;0.9 |
Active | 1.1 | 537 | 0.7 | 0.2;2.1 |
Uspecified gastrointestinal drugs at study entry | | | |
(Never-infrequent use) | 1.0 | 2029 | 1.0 | — |
Previous use | 1.6 | 124 | 2.1 | 0.5;10.0 |
Current use | 3.6 | 222 | 3.0 | 1.1;8.1 |
Minor tranquilliser use at study entry | | | | |
(Never-infrequent use) | 0.8 | 223 | 1.0 | — |
Previous use | 3.6 | 28 | 4.0 | 0.5;32.5 |
Current use | 4.5 | 112 | 3.4 | 1.2;10.0 |
NSAID use at study entry | | | | |
(Never-infrequent use) | 1.4 | 2079 | 1.0 | — |
Previous use | 0.5 | 185 | 0.4 | 0.1;2.8 |
Current use | 1.2 | 80 | 0.7 | 0.1;6.0 |